Skip to main content
SpringerLink
Log in

Setting the Frame or Framing Practice: The Never-Ending Guidelines Paradox

  • Commentary
  • Commentary
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;31(391):1301–14.

    Article  Google Scholar 

  2. Matsumoto M, Mouli SK, Saxena P, Gabr A, Riaz A, Kulik L et al. Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis. Cardiovasc Intervent Radiol. 2021; XXX

  3. Helmberger T, Golfieri R, Pech M, Pfammatter T, Arnold D, Cianni R, et al. Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT). Cardiovasc Intervent Radiol. 2021;44:21–35.

    Article  Google Scholar 

  4. Loffroy R, Ronot M, Greget M, Bouvier A, Mastier C, Sengel C, et al. Short-term safety and quality of life outcomes following radioembolization in primary and secondary liver tumours: a multi-centre analysis of 200 patients in France. Cardiovasc Intervent Radiol. 2021;44:36–49.

    Article  Google Scholar 

  5. Hermann AL, Dieudonné A, Ronot M, Sanchez M, Pereira H, Chatellier G, et al. Relationship of tumor radiation-absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90y in the SARAH study. Radiology. 2020;296:673–84.

    Article  Google Scholar 

  6. Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, de Baere T, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2021;6:17–29.

    Article  Google Scholar 

Download references

Funding

This study was not supported by any funding.

Author information

Authors and Affiliations

  1. Department of Radiology, Hôpital Beaujon, APHP.Nord, Clichy, France

    Maxime Ronot

  2. Université de Paris, Paris, France

    Maxime Ronot

  3. Interventional Radiology, Gustave Roussy, Villejuif, France

    Thierry de Baere

  4. Université Paris-Saclay, Villejuif, France

    Thierry de Baere

Authors
  1. Maxime Ronot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thierry de Baere
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thierry de Baere.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical Approval

For this type of study formal consent is not required.

Informed Consent

For this type of study informed consent is not required.

Consent for Publication

For this type of study consent for publication is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ronot, M., de Baere, T. Setting the Frame or Framing Practice: The Never-Ending Guidelines Paradox. Cardiovasc Intervent Radiol 44, 1683–1684 (2021). https://doi.org/10.1007/s00270-021-02912-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-021-02912-3

Search

Navigation